Erratum: Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis (Mucosal Immunology (2015) 8 (699) DOI:10.1038/mi.2015.22);Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis

Mucosal Immunology

Volumn 8, Issue 6, 2015, Pages 1324-1338

  Aherne, C M ^a   Saeedi, B ^a   Collins, C B ^a,b   Masterson, J C ^a,b   Mcnamee, E N ^a   Perrenoud, L ^a   Rapp, C R ^a   Curtis, V F ^a   Bayless, A ^a   Fletcher, A ^a   Glover, L E ^a   Evans, C M ^a   Jedlicka, P ^a   Furuta, G T ^a,b   De Zoeten, E F ^a,b   Colgan, S P ^a   Eltzschig, H K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; BAY 60 6583; CYCLIC AMP DEPENDENT PROTEIN KINASE; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE SEVERITY; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ACUTE DISEASE; ANIMAL; C57BL MOUSE; COLITIS; DISEASE MODEL; EPITHELIUM CELL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUNEL ASSAY; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; BLOTTING, WESTERN; COLITIS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION;

EID: 84945185710     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.41     Document Type: Erratum

References (49)

1. Khor B., Gardet A., & Xavier R.J Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011
2. Molodecky N.A., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54 e42 (2012
3. Aherne C.M., Kewley E.M., & Eltzschig H.K The resurgence of A2B adenosine receptor signaling. Biochim. Biophys. Acta 1808, 1329-1339 (2011
4. Lukashev D., Ohta A., Apasov S., Chen J.F., & Sitkovsky, MCutting edge: physiologic attenuation of proinflammatory transcription by the Gs proteincoupled A2A adenosine receptor in vivo. J. Immunol. 173, 21-24 (2004
5. Impellizzeri D., et al. CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. Eur. J. Pharmacol. 668, 305-316 (2011
6. Chouker A., et al. Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway. Mol. Med. 14, 116-123 (2008
7. Ohta A., & Sitkovsky, M Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-920 (2001
8. Eckle T., et al. A2Badenosine receptordampens hypoxia-induced vascular leak. Blood 111, 2024-2035 (2008
9. Csoka B., et al. A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J. Immunol. 185, 542-550 (2010
10. Koeppen M., et al. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology 116, 1245-1257 (2012
11. Schingnitz U., et al. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 184, 5271-5279 (2010
12. Frick J.S., et al. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J. Immunol. 182, 4957-4964 (2009
13. Aherne C.M., et al. Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis. Gut 61, 695-705 (2012
14. Louis N.A., et al. Control of IFN-alphaA by CD73: implications for mucosal inflammation. J. Immunol. 180, 4246-4255 (2008
15. Friedman D.J., et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 106, 16788-16793 (2009
16. Antonioli L., et al. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J. Pharmacol. Exp. Ther. 322, 435-442 (2007
17. Naganuma M., et al. Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J. Immunol. 177, 2765-2769 (2006
18. Alam M., Wilson J., & Ernst, P Role of adenosine A2B receptors in regulating inflammatory responses of TNBS-induced experimental colitis. J. Immunol. 184, 87.2 (2010
19. Kolachala V.L., et al. A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 135, 861-870 (2008
20. Kolachala V., et al. Blockade of adenosine A2B receptors ameliorates murine colitis. Br. J. Pharmacol. 155, 127-137 (2008
21. Ingersoll S.A., et al. A((2)B)AR expression in non-immune cells plays an important role in the development of murine colitis. Dig. Liver Dis. 44, 819-826 (2012
22. Kolachala V., et al. TNF-alpha upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cell. Mol. Life Sci. 62, 2647-2657 (2005
23. Eckle T., et al. Cardioprotection by ecto-5-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115, 1581-1590 (2007
24. Baraldi P.G., Tabrizi M.A., Fruttarolo F., Romagnoli R., & Preti, D Recent improvements in the development of A(2B) adenosine receptor agonists. Purinergic Signal. 4, 287-303 (2008
25. Ivanov A.I., Parkos C.A., & Nusrat, A Cytoskeletal regulation of epithelial barrier function during inflammation. Am. J. Pathol. 177, 512-524 (2010
26. Su L., et al. TNFR2 activatesMLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 145, 407-415 (2013
27. Xavier R.J., & Podolsky D.K Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007
28. Araki Y., Mukaisyo K., Sugihara H., Fujiyama Y., & Hattori, T Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice. Oncol. Rep. 24, 869-874 (2010
29. Van der Sluis M., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117-129 (2006
30. Khoury J., Ibla J.C., Neish A.S., & Colgan S.P Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J. Clin. Invest. 117, 703-711 (2007
31. Turner J.R., et al. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273, C1378-C1385 (1997
32. Majumdar S., & Aggarwal B.B Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 22, 1206-1218 (2003
33. Bergmann S., et al. Adenosine and homocysteine together enhance TNFmediated cytotoxicity but do not alter activation of nuclear factor-kappa B in L929 cells. J. Immunol. 153, 1736-1743 (1994
34. Tambuwala M.M., et al. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 139, 2093-2101 (2010
35. McNamara N., et al. Adenosine up-regulation of the mucin gene, MUC2, in asthma. FASEB J. 18, 1770-1772 (2004
36. Parkos C.A., et al. Intestinal epithelia (T84) possess basolateral ligands for CD11b/CD18-mediated neutrophil adherence. Am. J. Physiol. 268, C472-C479 (1995
37. + switch. Am. J. Physiol. Cell Physiol. 282, C1235-C1245 (2002
38. Odashima M., et al. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129, 26-33 (2005
39. Selmeczy Z., Csoka B., Pacher P., Vizi E.S., & Hasko, G The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice. Inflamm. Res. 56, 204-209 (2007
40. Yan Y., et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 4, e6073 (2009
41. Alex P., et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 15, 341-352 (2009
42. Sitaraman S.V., et al. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J. Clin. Invest. 107, 861-869 (2001
43. Collins C.B., et al. Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function. Mucosal Immunol. 6, 960-971 (2013
44. Siegmund B., et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1264-R1273 (2001
45. Burns R.C., et al. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in theSAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology 121, 1428-1436 (2001
46. Schulte G., & Fredholm B.B Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol. Pharmacol. 58, 477-482 (2000
47. Haeberle H.A., et al. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS One 3, e3352 (2008
48. Gessi S., et al. Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype. J. Cell Physiol. 211, 826-836 (2007
49. Keely S., et al. Dexamethasone-pDMAEMA polymeric conjugates reduce inflammatory biomarkers in human intestinal epithelial monolayers. J. Control Rel. 135, 35-43 (2009